Replies to post #15620 on Ariad Pharmaceuticals Inc fka ARIA

[Whosetosay]

I would have thought endo was a reasonably sized indication. Makes one wonder, if not endo, then what else (besides sarcoma)will they do with their investment in Rida, besides use it to position to buyout ARIA?